NCT00117286 2025-12-18
Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
Ferring Pharmaceuticals
Phase 2/3 Completed
Clinical Trials
27 trialsNCT05137561 2025-08-07
PROBIOP
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3 Completed
NCT03822845 2025-04-17
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT06601205 2024-09-19
2F
Ente Ospedaliero Ospedali Galliera
Phase 2/3 Completed
NCT03389451 2024-07-12
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT03388346 2024-02-15
68Ga PSMA in Preprostatectomy Patients
University of Iowa
Phase 2/3 Completed
NCT00584532 2023-11-24
GCP
University of California, Davis
Phase 2/3 Completed
NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT04627896 2023-02-02
Targeted Microwave Focal Therapy
A.O.U. Città della Salute e della Scienza
Phase 2/3 Completed
NCT02673151 2022-01-13
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Stanford University
Phase 2/3 Completed
NCT02981368 2021-08-09
OSPREY
Progenics Pharmaceuticals, Inc.
Phase 2/3 Completed
NCT01006395 2019-07-05
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Austin Health
Phase 2/3 Completed
NCT01105338 2018-01-23
ProDiet
University of Bristol
Phase 2/3 Completed
NCT02935972 2017-01-23
Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy
Assiut University
Phase 2/3 Completed
NCT00553878 2016-10-14
AVIAS
Canadian Urology Research Consortium
Phase 2/3 Completed
NCT00215683 2015-04-01
An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer
Ferring Pharmaceuticals
Phase 2/3 Completed
NCT01715064 2014-02-10
Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients
University of Guelph-Humber
Phase 2/3 Completed
NCT00765479 2013-09-20
Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT01901042 2013-07-17
Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms
Federal University of Mato Grosso
Phase 2/3 Completed
NCT01825642 2013-04-05
Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer
University of Michigan
Phase 2/3 Completed
NCT01272648 2013-01-29
RePCa
Odense University Hospital
Phase 2/3 Completed
NCT00004071 2012-09-11
Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer
Pfizer
Phase 2/3 Completed
NCT00268892 2010-12-24
Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
Ferring Pharmaceuticals
Phase 2/3 Completed
NCT00136487 2009-12-09
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2/3 Completed
NCT00127478 2007-11-29
A Long Term Safety Study With Atrasentan
Abbott
Phase 2/3 Completed
NCT00421694 2007-10-08
Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
University of L'Aquila
Phase 2/3 Completed
NCT00164437 2005-09-14
CD-ROM Intervention for Prostate Cancer Screening
Centers for Disease Control and Prevention
Phase 2/3 Completed